| No. |
Company's Name |
Technology |
Details |
| 165 |
Chemport, Inc |
The developing the treatment for Rheumatoid arthritis by using ω-3 polyunsaturated fatty acids |
|
| 164 |
CHONG KUN DANG |
|
|
| 163 |
Chonnam National University |
Recombinant fusion protein produced by fusing Vibrio vulnificus flagellin and pathogenic antigens an |
|
| 162 |
Chosun Univ. |
Novel Cell-Killing Peptide |
|
| 161 |
Chung-Ang Univ. |
Human Rotavirus and Vaccine Composition Comprising Same |
|
| 160 |
Chung-Ang Univ. |
A Novel Method for Predicting Litter Size in Pigs by Evaluation of Semen |
|
| 159 |
Chungbuk National Univ. |
Composition for Stimulating Erythropoiesis Comprising Quercetin 3-O-β-(2＂-galloyl)-rhamnopyranoside |
|
| 158 |
ClariPi Inc. |
|
|
| 157 |
Corestem, Inc |
|
|
| 156 |
CrystalGenomics, Inc. |
|
|
| 155 |
CrystalGenomics, Inc. |
CG100649, "Tissue-Specific" Next Generation NSAID for Osteoarthritis (in Phase II Clinical Developme |
|
| 154 |
CrystalGenomics, Inc. |
CG400549, A Novel Antibiotic for Superbugs Including MRSA, VRSA, and VISA (in Phase I Clinical Devel |
|
| 153 |
Dadak company |
|
|
| 152 |
DAEHWA Pharm |
|
|
| 151 |
Daewon Pharm. Co., Ltd. |
|
|
| 150 |
Daewoong Pharmaceutical Co., Ltd. |
|
|
| 149 |
Daewoong Pharmaceutical Co., Ltd. |
Novel Neuropathic Pain Therapeutics : DWP05195 / Oncolytic Adenovirus Cancer Gene Therapy : DWP418 |
|
| 148 |
DELVER Incorporated |
|
|
| 147 |
Dolki Korea LTD. |
Low Concentration Hypochlorous Acid Producing Technology |
|
| 146 |
Dong-Guk Univ. |
Development of Drug for Vitiligo Treatment Using Histamine |
|
